Shanghai Kaibao Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Kaibao Pharmaceutical Company Limited with three other
companies in this sector in China:
Shanghai Shenqi Pharmaceutical Investment Management CoLtd
sales of 1.74 billion Chinese Renmimbi [US$272.58 million]
Jinhe Biotechnology Co Ltd
(1.46 billion Chinese Renmimbi [US$228.87 million]
of which 67%
was Medical Feeds Additives), and
Guilin Sanjin Pharmaceutical Co Ltd
(1.62 billion Chinese Renmimbi [US$253.72 million]
of which 93%
was Proprietary Chinese medicine).
During the year ended December of 2017, sales at
Shanghai Kaibao Pharmaceutical Company Limited were 1.57 billion Chinese Renmimbi (US$246.54 million).
increase of 4.9%
versus 2016, when the company's sales were 1.50 billion Chinese Renmimbi.